Skip to main content
Cellular and Molecular Life Sciences: CMLS logoLink to Cellular and Molecular Life Sciences: CMLS
. 2006 Sep 28;63(19-20):2405–2414. doi: 10.1007/s00018-006-6248-7

Specific cleavage of insulin-like growth factor-binding protein-1 by a novel protease activity

J Wang 1, J Shafqat 2, K Hall 1, M Ståhlberg 2, I -L Wivall-Helleryd 1, K Bouzakri 1, J R Zierath 1, K Brismar 1, H Jörnvall 2, M S Lewitt 1,✉
PMCID: PMC11136341  PMID: 17006628

Abstract.

Insulin-like growth factor-binding protein-1 (IGFBP-1) is secreted in a highly phosphorylated form that binds IGF-I with high affinity and is resistant to proteolysis. We have purified IGFBP-1-specific protease activity from the urine of an individual with multiple myeloma. This protease efficiently cleaves both phosphorylated and non-phosphorylated IGFBP-1 at Ile130-Ser131, generating fragments that together have higher association and dissociation rates for IGFs compared with intact IGFBP-1. The proteolytic fraction contained azurocidin, a protease homologue hitherto considered inactive. After cleavage of IGFBP-1, there was a lower affinity, but higher capacity for IGF-I binding, suggesting both N- and C-terminal fragments may interact with ligand independently. There was decreased inhibition of IGF-II-stimulated cell growth and glucose uptake. Alone, proteolysed IGFBP-1 stimulated glucose uptake in muscle. We conclude that specific cleavage of IGFBP-1 at target tissues is important in cellular growth and metabolism and opens novel strategies for targeting IGFBP-1 in treatment of disease.

Keywords. Insulin-like growth factor, IGF-binding protein-1, proteolysis, skeletal muscle, catabolism, azurocidin/heparin binding protein/CAP37

Footnotes

Received 26 May 2006; received after revision 21 June 2006; accepted 24 August 2006


Articles from Cellular and Molecular Life Sciences: CMLS are provided here courtesy of Springer

RESOURCES